Background: Hypertension (HTN), which is a major risk factor for cardiovascular morbidity and mortality, can drive pathologic remodeling of the macro-and microcirculation. Patterns of aortic pathology differ, however, suggesting regional heterogeneity of the pressure-sensitive protease systems triggering extracellular matrix remodeling in the thoracic (TA) and abdominal aortas (AA). This study tested the hypothesis that the expression of two major protease systems (matrix metalloproteinases [MMPs] and cathepsins) in the TA and AA would be differentially affected with HTN.
Hypertension (HTN) represents a primary risk factor for cardiovascular morbidity and mortality and precipitates structural changes that may lead to aortic stiffness with associated downstream end-organ damage.
1,2 Clinical initiatives to increase diagnosis and treatment of HTN are underway, 3 but it is unclear whether the biochemical alterations driving aortic remodeling may be attenuated through current pharmacologic antihypertensive therapy. Moreover, evidence suggests that aortic remodeling may not represent a single pathologic process. 4 Structurally, the thoracic aorta (TA) has a greater diameter, greater wall thickness, more elastin, and more lamellar units, all of which contribute to the increased compliance within this region. 4 Uniform intraluminal pressure is also transduced through the stiffer, thinner abdominal aorta (AA) wall, thereby demonstrating how mechanosensitivity may differ between these segments to contribute to aortic regional heterogeneity. Aortic remodeling represents changes in the structure of the medial extracellular matrix (ECM) through local production of effector proteases. The factors manipulating cell signaling and gene expression have not been fully defined, but hemodynamic forces are expected to play a major role. For instance, ex vivo application of elevated mechanical stress has previously demonstrated increased transcription of collagen precursors, as well as matrix metalloproteinase (MMP)-2 and membrane type-1 (MT1) MMP. 5, 6 These enzymes have proven to make major contributions to the vascular remodeling associated with atherosclerosis and aneurysm disease, processes which are both closely linked to HTN. [7] [8] [9] Beyond local effects within the aortic wall, plasma levels of MMP-9 and the tissue inhibitor of metalloproteinase (TIMP)-1 are also elevated in hypertensive patients, 10 underscoring the systemic impact of chronic HTN. Considering the link between HTN and atherosclerosis, another vital family of matrix remodeling enzymes ought to be examined, the cathepsins. 11 These cysteine proteases primarily function within lysosomes, but several studies have identified extracellular impact because of vascular smooth muscle cell (VSMC) secretion in early atheromatous lesions, as well as aneurysm development. 12, 13 Whether VSMC production of cathepsins, and their primary inhibitor cystatin C, can be stimulated through mechanical forces has not yet been determined, however. The objective of this project is to demonstrate that differential protease profiles may be activated in the TA vs AA under conditions of uncontrolled HTN, suggesting that mechanical stress may initiate regionspecific pathologic aortic remodeling.
METHODS
Approval of the Medical University of South Carolina Institutional Review Board was not required for this study. All animal care and surgical procedures were approved by the Institutional Animal Care and Use Committee, AR#3380.
Murine hypertensive models. Two murine models of HTN were employed in the project. The first is a commercially available, spontaneously hypertensive mouse (BPH2; n ¼ 7) that initiates HTN at 5 weeks of age and peaks at 21 weeks (Jackson Laboratories, Bar Harbor, Maine). A low circulating angiotensin I volume has been recorded in these mice; suggesting that their HTN is angiotensin-independent.
14 The corresponding normotensive strain (BPN3; n ¼ 8) was used for control as well as for the second hypertensive model consisting of the well-established angiotensin II (AngII) model of continuous infusion for 28 days (1.46 mg/kg/day; n ¼ 8).
15-17
Mini-osmotic pump implantation and tissue harvest. Following induction of full anesthesia with 3% isoflurane and subcutaneous injection of 0.05 mg/kg buprenorphine, BPN3 mice (14-16 weeks of age) underwent subcutaneous left flank implantation of an Alzet pump (model 1004; Durect Corporation, Cupertino, Calif) that infused 1.46 mg/kg/day AngII for 28 days. Blood pressure was measured immediately prior to pump implantation and at terminal study 28 days postimplantation, using the CODA8 tail-cuff method (Kent Scientific Corporation, Torrington, Conn). Briefly, mice were placed in the restraint corridor and allowed at least 10 minutes of acclimation. The area was warmed with a heating pad and a quiet, dark environment was maintained to ensure reliable measurements within the parameters of this technology.
Full anesthesia was initiated for the terminal study, and the TA and AA were harvested by posterolateral thoracotomy and laparotomy, respectively. Tissue harvest included the descending TA from the crossing azygous vein to the diaphragmatic hiatus and the AA from the left renal vein to the bifurcation. The endothelium was denuded, and the aortas were snap frozen for biochemical analysis. BPH2 mice underwent aortic tissue harvest for biochemical analysis as described above at 16-20 weeks of age, after tail-cuff pressure measurement. Likewise, BPN3 control mice had tail-cuff blood pressure measurements at 12-20 weeks of age prior to aortic tissue harvest and processing for biochemical analysis.
Quantitative polymerase chain reaction. Total RNA was extracted using TRIzol (ThermoFisher Scientific, Waltham, Mass). One microgram of total RNA was reverse transcribed and converted to complementary DNA (cDNA) using the iScript cDNA synthesis kit (Bio-Rad, Hercules, Calif). Each cDNA sample was amplified with messenger RNA (mRNA) specific TaqMan Gene Expression Assays from ThermoFisher Scientific on a CFX-96 plate real-time polymerase chain reaction (PCR) machine (Bio-Rad). The relative expression of each mRNA was calculated and normalized to the expression of glyceraldehyde 3-phosphate dehydrogenase. Statistical analysis. Quantitative PCR (QPCR) and protein data were analyzed for normality with the Shapiro-Wilk test and found to be non-normally distributed. The data were then log-transformed (as determined by ladder of power followed by Shapiro-Wilk) prior to statistical analysis. For QPCR data, after log transformation, the fold change in expression from region-specific normotensive BPN3 control mouse aortas was graphed for each analyte in each hypertensive group. Mean differences were determined by one-way analysis of variance (ANOVA) with Bonferroni post-hoc correction. For protein data, results were graphed as a percent change from control. For statistical purposes, the log-transformed data were subjected to a one-sample mean comparison vs 100%, followed by one-way ANOVA with Bonferroni post-hoc correction. All values were reported as a mean 6 standard error of the mean. Stata (v 8.2) statistical software (Intercooled, College Station, Tex) was used for all calculations, and values of P < .05 were considered significant.
RESULTS
Following 28 days of infusion, the BPN3þAngII mice had a 17% increase in systolic blood pressure, matching that of the BPH2 spontaneously hypertensive mice (both P < .05 vs BPN3, Fig 1) . Fold change in gene transcription was explored in the nine target genes via QPCR and the results have been summarized in Figs 2 and 3. MMP-2 expression was decreased in both aortic regions of the BPH2 spontaneously hypertensive mice, but more interestingly, a significant difference between the mRNA levels in TA of BPN3þAngII and BPH2 mice was identified, suggesting an AngII-dependent expression pattern (Fig 2, A ; P < .05). MMP-9 expression was not significantly altered in any hypertensive groups (Fig 2,  B) . The AA of both hypertensive models demonstrated decreased MT1-MMP expression, however, suggesting a pressure-dependent effect in this region (Fig 2, C ; P < .05).
The potent elastase cathepsin S was unchanged in the aortas of hypertensive mice (Fig 2, D) , but cathepsin K responded to AngII-induced HTN with significantly elevated expression in the TA of those mice compared with BPH2 (Fig 2, E ; P < .05). Compared with normotensive controls, the AA of both hypertensive models had decreased cathepsin L mRNA, again suggesting a pressure-dependent profile in this region (Fig 2, F ; P < .05).
Given that the balance of proteolytic activity within the ECM relies heavily on local production of inhibitor proteins, primary endogenous inhibitors were also evaluated under hypertensive conditions. Expression of TIMP-1 was markedly increased in TA of BPN3þAngII mice, and there was also a significant difference compared with the TA region of BPH2 mice, suggesting an AngII-dependent contribution (Fig 3, A ; P < .05). TIMP-2, on the other hand, appeared to be pressure-dependent and demonstrated decreased expression in the TA of BPH2 mice as well as the AA of both hypertensive groups (Fig 3, B ; P < .05). Interestingly, gene expression of the primary cathepsin inhibitor cystatin C was likewise statistically decreased in both AA groups (Fig 3, C ; P < .05). Given the significant implications for matrix remodeling, the pressure-dependent vs AngII-dependent expression of proteases in the hypertensive murine aorta has been summarized in the Table. Zymography and immunoblot analysis of aortic homogenates were conducted to further evaluate proteolytic changes in the TA vs AA of hypertensive mice, and the results have been summarized in Fig 4 as a percent change from control normotensive BPN3 mice. One-way ANOVA did not identify any significant differences among the quantifiable target genes, but subsequent paired analysis was pursued with one-way t-test. Interestingly, MMP-2 zymographic activity was decreased in the AA of both hypertensive models, following the pressure-sensitive decrease in gene transcription in these regions (Fig 4, A ; P < .05 by one-sample t-test). MMP-9 activity was decreased in the TA of BPH2 mice (Fig 4, B ; P < .05 by one-sample t-test) and MT1-MMP abundance was decreased in the AA of BPN3þAngII mice (Fig 4, C ; P < .05 by one sample t-test), but no inhibitor proteins demonstrated a significant difference in either aortic region. Consistent with prior literature and the modest alterations in mRNA expression under hypertensive conditions, cathepsin protein levels were unable to be quantified via immunoblot in nonaneurysmal murine aorta.
Given the significant decrease in protease production observed in the BPH2 mice, there was concern for VSMC apoptotic loss in this model; therefore, samples were evaluated for expression of the p53-upregulated mediator of apoptosis. This gene demonstrated decreased expression in the AA of both hypertensive models, and there was no change in protein abundance, suggesting that altered gene expression was unlikely to be related to cell death (Fig 5, A and B ; P < .05).
DISCUSSION
Uncontrolled HTN contributes to remodeling of the aortic wall with subsequent increased stiffness and significantly elevated risk of cardiovascular morbidity and mortality. 2 Mechanical strain can stimulate VSMC production of specific fibrillar ECM proteins, such as versican and perlecan 18 ; therefore, pressure-induced synthesis of proteases to further modify ECM structure and function may be expected. Regional heterogeneity in baseline aortic structure and function must be considered, however, and by utilizing two different models of HTN, this study has identified pressure-dependent as well as AngII-dependent regional alterations in aortic gene expression. Further investigation into mechanosensitive signaling pathways in TA vs AA is expected to provide insight into the contribution of AngII, the significance of regional factors, such as VSMC embryologic origin, the rate of progression to clinical disease, and the potential for site-specific therapeutic targets.
Relevance of AngII. AngII is one of the most extensively studied vasoactive peptides, and this hormone has particular relevance to the hypertensive remodeling addressed in this study. AngII is upregulated in systemic HTN and can directly increase peripheral vascular resistance through vasoconstriction, but also modulates the function of adhesion molecules, chemokines, cytokines, and growth factors to ultimately control cell proliferation, hypertrophy, fibrosis, and inflammation in the vessel wall. 19 Alterations in intrinsic aortic stiffness because of accumulation of collagen and additional matrix proteins, with or without concurrent production of MMPs, has been considered a response to mechanical stress. 20 AngII has been linked to inflammation-induced cathepsin production, but interestingly, cathepsin S and cathepsin K knockout mice were resistant to abdominal aortic aneurysm formation via the AngII infusion model, suggesting that the inducible expression of these proteases may be at least partially dependent on AngII. 21 Collectively, the potential for AngII to significantly impact medial cell gene expression in conjunction with mechanical stress warrants specific integration of this vasoactive peptide in this exploration of hypertensive aortic remodeling. By utilizing an AngII-induced hypertensive model beside a commercially available spontaneously hypertensive model reported to have low renin-angiotensin system activity, this project has identified that MMP-2 has increased gene expression under conditions of mechanical stress plus AngII, demonstrating the direct cellular effects of this peptide in the TA. Interestingly, TIMP-1 mRNA levels followed the same pattern of augmentation in the TA of BPN3þAngII mice, affirming that the MMP:TIMP continues to be of primary concern in this region. In addition, cathepsin K demonstrated significantly altered gene expression in AngII-induced HTN in the thoracic aortic region, suggesting that both proteolytic systems respond to AngII and may collaborate to initiate aortic remodeling.
Implications of cellular origin. With interest in providing comprehensive preventive care to patients, tracking aortic stiffness through pulse wave velocity has proven clinically relevant as an early predictor of cardiovascular morbidity and mortality. 22 This prognostic test excludes the neural crest-derived ascending aorta from consideration, and extensive modeling would be necessary to adequately address the magnitude of shear forces and complex mechanical variables interacting in that dynamic aortic region. Quantification of aortic stiffness assumes a uniform aorta from carotid artery to femoral artery with consistent wall remodeling in response to hemodynamic stress, but biochemical, histologic, and mechanical evidence supports heterogeneity of aortic form and function. [23] [24] [25] [26] Embryologic origin of VSMCs may be at the root of regional remodeling variance; however, descending thoracic aortic VSMCs develop from somites whereas those of the AA and peripheral vasculature are mesoderm-derived. 27 Functional diversity to biochemical stimuli has been previously demonstrated in VSMCs of different embryologic origin, 23 and mechanical strain has been demonstrated to activate reactive oxygen species and mitogen-activated protein kinases to promote production of matrix proteins, proteases, and apoptotic mediators. 5, 18, 28 This investigation into protease production in the TA vs AA segments of hypertensive mice has allowed specific investigation of the lineage-dependent medial cell transcription response to elevated pressure, with and without concurrent AngII stimulation, and demonstrated significant variation in activity. Regional mechanosensitive signaling. Thoracic aortic remodeling involves restructuring of the ECM through the activity of several proteases. The MMP-2 and MT1-MMP transcriptional activity observed in this study is contradictory to that previously described for an ex vivo method of tension application. 6, 29 Specifically, there was an unexpected decrease in expression of MMP-2 and a lack of significant response of MT1-MMP in BPH2 TA mice, demonstrating that moderate increase in blood pressure was insufficient to stimulate protease production and initiate remodeling. Prior investigation into stretchdependent signaling of rat thoracic aortic VSMCs in vitro has identified activation of the classic mitogenactivated protein kinase system in both endothelialintact and endothelial-denuded vessels. 30, 31 None of the cathepsins evaluated in this project responded to isolated elevated wall tension in the TA, suggesting that additional stressors, such as inflammatory cytokines are necessary to induce expression of this protease. 12 Given that increased apoptosis was not identified in this project, the decreased MMP-2 production identified in the TA of BPH2 mice may represent preferential expression of peptides promoting cell proliferation, adhesion, or hypertrophy rather than matrix degradation, and further exploration of biomechanical signaling pathways will be necessary to translate the degree and duration of elevated tension necessary to initiate vascular remodeling. Understanding HTN-induced VSMC cell signaling pathways in the AA may help characterize expression patterns that drive the preferential atherosclerotic plaque deposition in this aortic region. In this study, HTN created a trend to decreased MT1-MMP expression, and this response was similar within both models. A similar decrease was identified for TIMP-2, the other vital component of the MMP-2 activation complex, demonstrating integration of the MMP/TIMP ratio in this region. The lack of response in MMP-9 also supports prior research suggesting this protease may be primarily secreted by inflammatory cells infiltrating the aortic region, rather than native medial aortic cells, and this potential etiology will be explored in future studies. 32 MMP activity can also be regulated by urokinase plasminogen activator, and the abundance of this protease may represent another biochemical modulator to influence tension-induced aortic remodeling. 33, 34 Considering the prior association of cathepsins with abdominal aneurysm, 35, 36 upregulation in the hypertensive state may have been expected as a precursor to degenerative remodeling, but under mechanical stress alone, cathepsins S and K were unchanged from baseline while cathepsin L was significantly decreased in the AA of hypertensive mice. Cystatin C also demonstrated pressure-sensitive decrease in expression in the AA, however, providing another means of imbalanced proteolytic activity to drive matrix remodeling. Future use of expanded experimental techniques to quantify these lysosomal proteases at baseline may significantly expand our opportunity to investigate their role in hypertensive remodeling. The necessary contribution of inflammatory cytokines to augment hypertensive cathepsin expression ought to be further explored, as well to elucidate the differential pathways of activation within the cathepsin family of proteases. Overall, these results demonstrate that both major aortic protease systems, along with the respective inhibitors, can be impacted by VSMC mechanosensitivity in the AA with pressure-dependence manifesting decreased protease expression, therefore, the anticipated pressure-induced stimulation of protein production may be skewed toward pathways contributing to cellular hypertrophy or proliferation rather than matrix degeneration.
Limitations. Identifying major proteases contributing to aortic medial ECM remodeling under hypertensive conditions poses opportunities to define new targeted therapies, but controlling for confounding factors may present limitations to the current study. Infusion of AngII is a well-accepted hypertensive model, but the known effect on native cell signaling may obscure the tensionsensitive signaling effects. This potential for AngII to directly impact cellular gene expression, rather than or in addition to the elevated blood pressure effects, was addressed by using the BPH2 spontaneously hypertensive mice. This strain has demonstrated elevated blood pressure in the absence of an elevated reninangiotensin-aldosterone hormone network and provides a unique opportunity to evaluate isolated wall tension. Future comparisons between the hypertensive models will be enhanced by additional characterization of the vasoactive, inflammatory, and neurohormonal properties of the BPH2 mice. An additional potential limitation of this study is the removal of the intima prior to examining MMP and cathepsin production by VSMCs under conditions of HTN. It has been well-established that endothelial cells respond to hemodynamic stimuli as well as AngII, and it was believed that inclusion of these cells could misdirect the investigation where alterations in cell signaling of the aortic media were of primary concern. Adventitial fibroblasts would also be included in the aortic homogenate but are expected to be less responsive to mechanical stimuli. Accounting for adventitial protease production may be further analyzed via immunohistochemistry in subsequent investigations. Lastly, acknowledging the overlap of protease production from infiltrating inflammatory cells as well as native VSMCs, histologic analysis of aortic walls in each region of the hypertensive models would provide a means to account for the differential inflammatory infiltrate that may further contribute to disparate protease production.
Finally, although the regional comparison of aortic remodeling within this study focused on two areas of frequent fusiform aneurysmal degeneration, the aortic pathology includes a more extensive array of abnormalities. Tension-related predisposition to dissection and aneurysm formation in the ascending aorta, for instance, likely represents a unique protease complex and this neural crest-derived region has previously demonstrated a degenerative response to AngII infusion. 37 Likewise, the paravisceral segment of hypercholesterolemic mice responded to AngII infusion by forming a dissecting aneurysm with medial matrix degeneration, re-endothelialization, and adventitial stability. 38 Considerations of regional variability in aortic response to hemodynamic and vasoactive stimuli, therefore, encompass anatomic, as well as histologic zones, and require further exploration for full characterization.
CONCLUSIONS
Poorly controlled HTN affects millions of Americans, and the subsequent aortic remodeling contributes to the high rate of cardiovascular mortality in this population. Regional heterogeneity in healthy aortic structure and function is expected to persist in pathologic remodeling. By using two unique models of HTN, this study has identified pressure-dependent, as well as AngII-dependent, regional alterations in aortic gene expression of MMPs and cathepsins that may lead to differential remodeling responses in each of the aortic regions. Further studies will delineate mechanisms and may provide targeted therapies to attenuate downstream aortic pathology based on demonstrated regional heterogeneity. 
DISCUSSION
Dr Bauer E. Sumpio (New Haven, Conn). Thank you, Dr Ruddy for that clear presentation and for sending me updated copies of your manuscript. You and your group are to be congratulated for continuing on this line of research that draws attention to the anatomic and physiologic differences between the thoracic aorta (TA) and abdominal aorta (AA), which may have some bearing on the incidence and natural history of vascular disease in these regions. In this current study, the focus is on hypertension (HTN) and vascular remodeling of the TA and AA. The problem is that the etiology of HTN is heterogeneous. HTN can be essential, the etiology of which is unclear and thought to be resulting from the interaction of multiple genetic and environmental factors, or secondary to a defined process, such as renal artery stenosis. The pathophysiology of essential HTN is also heterogeneous and varies by age, renin status, sodium dependency, and other characteristics. Therefore, several experimental models have been developed to mimic the many facets of human HTN.
As we heard, the authors use two mouse models of HTN. The first is a commercially available, spontaneously hypertensive mouse that initiates HTN at 5 weeks of age. The HTN in these mice has been recognized as neurogenic with over activity of the sympathetic nervous system as ganglion blockade abolishes the HTN. For the second model of HTN, the authors used the normotensive strain of the mouse and infused angiotensin II (AngII) through an implanted pump for 28 days. The authors then compared tissue from the TA and AA form both mRNA and protein levels of matrix metalloproteinases (MMPs) and cathepsin.
I have three sets of questions that relate to the methodology, quality of the results and the significance of the study.
First, regarding the methods and design of the study, it appears that you may be really comparing an acute model of HTN with a chronic model of HTN since you are comparing 28 days of infusion of AngII with the genetically hypertensive mice that have been gradually hypertensive for at least 10 weeks (BPN/3J mice 14-16 weeks old, but HTN starts at 5 weeks). I believe that experiments consisting of a time course analysis of AngII would be helpful to clarify this, as would experiments clarifying the confounding effects of a sham operation on the hypertensive mice. In addition, in your aortic tissue analysis you scrape off the endothelium so you may be missing a significant effect of AngII on endothelial cells.
Second, regarding the results, there are some interesting but curious findings. For example, you demonstrate a significant decrease in mRNA for MMP-9 in both hypertensive models. Are you implying that there is inhibition or breakdown of mRNA? In the article you mention immunoblots, but no data is shown and you describe concordant changes in the zymograms measuring protein levels with then mRNA analyses. Could you speculate on this? Does regulation of the pressure sensitive genes only occurs at transcriptional level or is it a delayed protein response? Is zymography not sensitive enough or is it due to low numbers of mice in each group and so large standard error? Furthermore, the scales of transcriptional response for TA are so much greater than for AA.
Lastly, regarding the interpretation of the results and the significance of the study. There are number of mouse models of HTN and there are considerable differences between HTN in animals and humans, such as differences in homeostatic mechanisms and pathophysiology. Could you comment on the relevance of your neurogenic and AngII infusion mouse model to human HTN? I wonder if you could also speculate on the potential role for the use of MMP inhibitors in hypertensive patients.
Thank you for the privilege of floor to discuss this thoughtful article that addresses a critically important issue of differential vascular remodeling of the TA and AA with HTN.
Dr Jean Marie Ruddy. Thank you, Dr Sumpio, those are really fantastic questions. To address your first question regarding whether we are really comparing acute and chronic hypertensive models, I completely agree that we certainly are catching the AngII group at a 4-week timeframe, which could be considered an acute model vs the more prolonged HTN identified in the BPH2 model. As you mentioned, it really starts to be hypertensive at only 5 weeks of age. We do hope to address that with an additional set of experiments looking at potentially an 8-week implantation of AngII infusion and to determine whether we see differences within our protease expression in both regions with increased duration of AngII delivery and also to determine whether we get a more significant hypertensive response over that timeframe. Does the degree of HTN continue to increase when the treatment with AngII is brought out an additional 4 weeks, which may also provide very interesting answers to how much of a role mechanotransduction is really providing vs AngII specific effects within cell signaling of the aortic media.
The removal of the endothelial cells certainly does inhibit our ability to fully understand what happens in the hypertensive state. However, to effectively measure what may be going on in the aortic media where a large amount of the matrix remodeling occurs. To target this pathologic process, it was an effective starting point to remove the endothelial cells and isolate the function of the smooth muscle cells. We do hope in the future to repeat the studies with the endothelium in place. We know that sheer stress and HTN certainly affects endothelial cell gene expression as well as AngII and that has certainly been demonstrated for both cathepsins and MMPs, so ideally this contribution is something we may be able to explore in the future.
With regard to the mRNA levels appearing to be decreased in several of the proteases under hypertensive circumstances, that certainly was somewhat surprising to us as well. I believe what we may be seeing is a timeframe of medial cell and possibly vascular smooth muscle cell hypertrophy rather than expression of proteases to initiate remodeling of the nearby matrix and as we continue with this project, we may begin to look at collagen and ground substance production to see if these structural genes are activated at earlier timeframes of HTN. I do believe that there is likely some component of post-transcriptional modification leading to the differences in our mRNA and protein levels, but these are also low copy number genes, so detecting changes may be further influenced by lack of degradation. And then finally, just to briefly touch on your last question about relevance to humans, what I really believe we will be able to do with this project by employing two different hypertensive models is get into some of the various etiologies of HTN within the human condition to determine if there are alternative targets that we may be able to use to effectively reduce vascular remodeling in patients.
